Key result
Individualised tricuspid valvuloplasty is linked to 100% resolution of severe pediatric tricuspid regurgitation.
Why the study?
Isolated congenital tricuspid regurgitation other than Ebstein's anomaly is rare in children, and clinical characteristics and surgical outcomes are not well described.
Does individualized tricuspid valvuloplasty improve tricuspid regurgitation severity and functional class in children with isolated tricuspid regurgitation?
Observational (n=10)
No
Does individualized tricuspid valvuloplasty improve tricuspid regurgitation severity and functional class in children with isolated tricuspid regurgitation?
Individualized tricuspid valvuloplasty is an effective treatment for children with isolated severe tricuspid regurgitation unresponsive to medical therapy, yielding excellent mid-term functional outcomes.
BACKGROUND: Isolated congenital tricuspid regurgitation other than Ebstein's anomaly was rare especially for children. The objective of this study was to investigate the clinical characteristics and to assess the results of tricuspid valvuloplasty for children with isolated tricuspid regurgitation. METHODS: From January 2010 to June 2019, 10 consecutive patients with isolated tricuspid regurgitation who were unresponsive to drug therapy underwent tricuspid valvuloplasty in our hospital. Patients' clinical data were analysed retrospectively. RESULTS: Mean age at operation was 48.5 ± 31.0 (range: 9-106) months and mean weight at operation was 16.1 ± 6.9 (range: 8.6-33.0) kg. All patients presented severe isolated tricuspid regurgitation. According to pathological lesions, the main causes accounted for chordae tendinea rupture (3/10), leaflet cleft (2/10), mal-connected chordal tendinea to leaflets (2/10), elongated chordae (1/10) and chordae absent (1/10), and severe anterior leaflet dysplasia (1/10). Individualised tricuspid valvuloplasty was adapted to all of them successfully. Post-operative echocardiography showed no tricuspid regurgitation in two patients and mild regurgitation in eight patients. The cardiothoracic ratios on their chest roentgenograms decreased from 0.59 ± 0.05 to 0.54 ± 0.05. At the latest follow-up (50.4 ± 47.2 months), echocardiography showed that mild to moderate tricuspid regurgitation in seven patients, moderate tricuspid regurgitation in three patients, and no patient with severe tricuspid regurgitation. All patients were in NYHA functional class I. CONCLUSIONS: For patients with isolated tricuspid regurgitation who were not well responsive to drug therapy, individualised tricuspid valve repair can achieve an excellent result.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) conducted an observational in Isolated tricuspid regurgitation (n=10). Individualised tricuspid valvuloplasty was evaluated on Tricuspid regurgitation severity and NYHA functional class at latest follow-up. Individualised tricuspid valvuloplasty in 10 children with severe isolated tricuspid regurgitation eliminated severe regurgitation and achieved NYHA class I in all patients at 50.4 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: